T he Amelogenesis Imperfecta (AI) are a group of clinically and genetically heterogeneous disorders that affect enamel development, resulting in abnormalities of amount, composition, and/or structure of enamel. Although enamel appearance (hypoplastic, hypomature, or hypocalcified) and mode of inheritance (autosomal-dominant, autosomal-recessive, or X-linked) have historically been used to classify AI into 14 subtypes (Witkop, 1988) , current classifications of AI are problematic (Hart et al., 2002a; Nusier et al., 2004) . Development of a more robust nosology for AI will require a greater understanding of how enamel development is altered. This will necessitate identification of the genetic etiology of various forms of AI, and an understanding, at the molecular level, of how mutations of these genes affect enamel development.
INTRODUCTION
T he Amelogenesis Imperfecta (AI) are a group of clinically and genetically heterogeneous disorders that affect enamel development, resulting in abnormalities of amount, composition, and/or structure of enamel. Although enamel appearance (hypoplastic, hypomature, or hypocalcified) and mode of inheritance (autosomal-dominant, autosomal-recessive, or X-linked) have historically been used to classify AI into 14 subtypes (Witkop, 1988) , current classifications of AI are problematic (Hart et al., 2002a; Nusier et al., 2004) . Development of a more robust nosology for AI will require a greater understanding of how enamel development is altered. This will necessitate identification of the genetic etiology of various forms of AI, and an understanding, at the molecular level, of how mutations of these genes affect enamel development.
To date, mutations in 4 genes-AMELX, ENAM, KLK4, and MMP20have been reported to cause AI in humans. Most cases of X-linked AI result from mutations in the AMELX gene that codes for amelogenin, the most abundant protein in enamel (Hart et al., 2002a,b; Wright et al., 2003; Kim et al., 2004) . Depending on the specific mutation, the phenotype associated with AMELX mutations can range from smooth hypoplastic to hypomineralized/hypomaturation (Hart et al., 2002b; Wright et al., 2003; Kim et al., 2004) . ENAM mutations are etiologic for some autosomal forms of hypoplastic AI, including both dominantly and recessively inherited forms (Rajpar et al., 2001; Kida et al., 2002; Mardh et al., 2002; Kim et al., 2005b) . Only one mutation each has been reported in genes encoding the enamel proteinases, matrix metalloproteinase 20 (MMP20) and kallikrein 4 (KLK4). These both result in a hypomaturation AI phenotype that is transmitted as an autosomalrecessive trait Kim et al., 2005a) .
In this study, members of 15 Turkish families identified through ascertainment of probands with hypomaturation AI segregating as an autosomal-recessive trait were evaluated for mutations in the MMP20 and KLK4 genes.
MATERIALS & METHODS

Pedigrees and Diagnosis
Individuals affected with hypomaturation AI were identified in the dental clinics at the School of Dentistry, Istanbul University. Informed consent was obtained according to the Declaration of Helsinki. Available family members received an oral examination, including dental radiographs, to determine if they had AI. Fifteen families were identified with hypomaturation AI, characterized by opaque, whitish, yellowish to brownish enamel with radiographically evident decreased contrast between dentin and enamel. The thickness of the enamel was not affected, but because the enamel was often softer than normal, it could be abraded on the incisal/occlusal surfaces. Eleven of the 15 families reported a
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Mutation Analysis
Genomic DNA was isolated from whole blood with the QIAamp DNA Blood Maxi Kit (Qiagen Inc., Valencia, CA, USA). The oligonucleotide primers and conditions used to amplify and sequence all exons, including introns/exon splice sites for KLK4 and MMP20 amplification, were described previously Kim et al., 2005a) . Amplification products were sequenced on an ABI 3100 automated DNA sequencer. Sequence data were compared with reference sequences (MMP20: NT_033899) (KLK4: AF228497) using the Sequencher program (Gene Codes Corporation, Ann Arbor, MI, USA). One hundred healthy Turkish control individuals were also sequenced for MMP20.
Protein Expression
The full-length human MMP20 cDNA containing open reading frame (ORF) was generated by PCR, with MMP20 specific primers: 5Ј-CTA CTG TGA GGG GAT GAA GG-3Ј (SS) and 5Ј-TTT CTA TTT AGC AAC CAA TCC-3Ј (AS), AccuPrime TM Pfx polymerase (Invitrogen, Carlsbad, CA, USA), and human tooth cDNA library as a template. The PCR product was cloned into the TA vector (Invitrogen), sequence-verified, and subcloned into the pcDNA3.1 mammalian expression vector (Invitrogen). The mutant MMP20 cDNA (g.16250T>A) was generated with primers (5Ј-GTT TAC CGT TGC TGC TCA AGA ATT TGG CCA TGC C-3Ј [SS] and 5Ј-GGC TAG GCC AAA TTC TTG AGC AGC AAC GGT AAA C-3Ј [AS], where bold represents the T>A mutated sequence) and the QuikChange Site-Directed Mutagenesis kit (Stratagene Inc., La Jolla, CA, USA), according to the manufacturer's instructions. Clones were sequence-verified. The wild-type and mutant MMP20 cDNAs in the pcDNA3.1 mammalian expression vector were transfected into HEK293 cells by means of the lipofectamine plus transfection kit (Invitrogen). HEK293 cells transiently transfected with wild-type and mutant human MMP20 expression constructs were cultured in Dulbecco's Modified Eagle Media (DMEM), containing antibiotics without serum, for 48 hrs, to express human MMP20 proteins. The conditioned media were harvested and concentrated by ultrafiltration through an Amicon YM10 membrane (Millipore Inc., Bedford, MA, USA) for the Western blot and zymogram analyses. The expression vector pCDNA3.1 alone was transfected into HEK293 cells to serve as a negative control.
Western Blotting
The concentrated media were mixed with 4x NuPAGE SDS sample loading buffer (Invitrogen) containing ␤-mercaptoethanol, boiled for 5 min, and run in 12% NuPAGE Bis-Tris gel with MOPS-SDS running buffer (Invitrogen). Following electrophoresis, the gel was trans-blotted onto a PVDF membrane (Bio-Rad Laboratories, Inc., Hercules, CA, USA) and analyzed by Western blotting with an MMP20-specific polyclonal antibody (provided by Dr. James Simmer), at 1:1000 dilution, and HRPconjugated anti-chicken IgG antibody (Sigma-Aldrich Co., St. Louis, MO, USA) at 1:3000 dilution.
Zymography
Zymograms were performed on 4-16% SDS-polyacrylamide gradient gels containing casein. The concentrated media were mixed with 2 vol of zymogram sample loading buffer (Bio-Rad Laboratories) and incubated at 37°C for 10 min. Protein samples were run on a zymogram gel at a constant current of 20 mA. Following electrophoresis, the gel was washed (x3) for 15 min in 50 mL of 2.5% Triton X-100 solution (2.5% Triton X-100 in 50 mM Tris-HCl buffer [pH 7.4]). Gels were incubated at 37°C for 2 days in 50 mM Tris buffer (pH 7.4) containing 5 mM CaCl 2 and 1 mM MgCl 2 .
RESULTS
Clinical Findings
Probands from 15 families were identified with hypomaturation AI. Examination of the probands' first-degree relatives (n = 65) identified hypomaturation AI in five siblings and one parent. The pedigree of one family with a mutation is shown in Fig. 1 . The proband from this family had hypomaturation AI and an anterior open bite (Fig. 2) . Caries lesions were evident on the maxillary permanent central incisors as well as in primary and permanent molars. His affected sibling also had hypomaturation AI, an anterior open bite, and caries on primary and permanent posterior teeth (Fig. 3 ).
Mutation Results
No KLK4 gene mutations were found in any probands. One family (Fig. 1 ) was found to have 4 MMP20 sequence alterations: g.18661T>C, g.18679C>A, g.31605G>A, and g.16250T>A. The first 3 genetic variants were found in the SNP database, indicating that they are polymorphisms present in at least 1% in the population, and therefore are unlikely to have any pathological effects (http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?db=snp): rs1784423, rs1784424, and rs1784440. The last alteration, an exon 5 single-base substitution (g.16250T>A), changes the DNA codon for the amino acid histidine (CAT) to glutamine (CAA) (p.H226Q; Fig. 1B ). His226 is an important catalytic site component of MMP20. The proband and his affected sister were both homozygous for this mutation, consistent with consanguinity. The parents, paternal grandfather, and maternal grandfather were all carriers of the mutation. Sequence analysis of 100 healthy Turkish controls (200 chromosomes) did not reveal this sequence alteration, indicating that this g.16250T>A mutation is not a common variant in the Turkish population.
Functional Studies
Recombinant human wild-type and mutant MMP20 cDNAs were transiently transfected into HEK293 cells, and the cultureconditioned media were collected and subjected to electrophoresis. Western blot analysis with an MMP20-specific antibody revealed that mutant and wild-type MMP20 cDNA produced a protein of approximately 45 kDa. This band was not detected in conditioned media from the negative control transfectant (data not shown). Casein zymograms performed to determine the protease activity of wild-type and mutant MMP20 revealed that the wild-type MMP20 protein cleaved the casein substrate (Fig. 1C) , whereas the mutant protein was unable to cleave the substrate, consistent with a loss of proteolytic function.
DISCUSSION
These findings represent the second MMP20 mutation, confirming that mutation of this gene is etiologic for some cases of autosomal-recessive hypomaturation AI (Table) . Individuals homozygous for the exon 5 g.16250T>A mutation have hypomaturation AI and anterior open bite. Enamel anomalies were observed in both the primary and secondary dentitions. Heterozygous carriers of the mutation do not have an enamel phenotype. MMP20, also called enamelysin (OMIM604629), is a member of the matrix metalloproteinase family, a group of zinc-dependent metallopeptidases involved in extracellular matrix remodeling (Nagase and Woessner, 1999; Simmer and Hu, 2002) . MMP20 is unique among the MMP family because of its highly restricted expression. In developing teeth, MMP20 is expressed primarily during the secretory to late-transition stages of amelogenesis (Bartlett et al., 1998) . With its specificity for amelogenin, the major organic component of the enamel matrix, MMP20 is considered a predominant enzyme for the processing of enamel matrix. Human MMP20 consists of 483 amino acids and shares extensive (89%) amino acid sequence identity with porcine MMP20 (Llano et al., 1997; Bartlett et al., 1998) . MMP20 has the characteristic domain structure of most other MMPs, including a signal peptide, a propeptide that maintains enzyme latency, a catalytic domain with a zinc-binding site, and a hinge region that links the catalytic domain to the C-terminal hemoplexin-like domain (Llano et al., 1997; Bartlett and Simmer, 1999) . Computer modeling of pig enamelysin with the use of several crystal structures determined that 3 highly conserved amino acids-His226, His230, and His236-are the active sites of the zinc catalytic domain (Ryu et al., 2000) . The g.16250T>A substitution mutation identified in this report changes the conserved active site His226 residue of the zinc catalytic domain (p.H226Q). The glutamine substitution destroys this metal-binding site and abolishes catalytic activity. Results of the biochemical assays in which the g.16250T>A mutant MMP20 demonstrates a complete lack of MMP20 activity corroborate these computational predictions. A similar clinical phenotype (hypomaturation AI) is also seen with homozygous mutations in KLK4 lacking the Ser207 active site of the catalytic triad .
MMP20 processes amelogenin to produce biologically active fragments that function during the initial developmental stages of enamel (Ryu et al., 1999) . The complete loss of MMP20 proteolytic activity may prevent proper processing and degradation of enamel matrix proteins, resulting in qualitative defects in enamel malformation. The mouse mmp20 null model indicates that MMP20 performs enamel matrix protein cleavages that are essential for processing and removal of enamel matrix proteins during the secretory and maturation stages of enamel development (Caterina et al., 2002; Bartlett et al., 2004) . mmp20 null mice do not process enamel matrix protein properly, yielding a severe AI phenotype, although hemizygous mice have no phenotype. Interestingly, the mature enamel in the mmp20 null mouse contained less bulk mineral (53%) and less weight percent of mineral (range, 7-16%) compared with controls, and was significantly (~ 37%) softer than normal enamel. AI-affected teeth of mmp20 null mice show attrition of the molar occlusal surfaces that is related to the time of eruption. A similar trend was observed in the affected siblings in the current report who showed such attrition on the primary molars (Figs. 2, 3) . The murine knock-out model suggests that there is no compensation for mmp20 function, indicating that it is necessary for proper enamel development. Clinical findings in individuals homozygous for the MMP20 g.16250T>A mutation indicate an analogous situation in human enamel development. The finding that heterozygous carriers (MMP20 g.16250T>A/wild-type) display no clinically apparent anomalies of enamel are similar to those observed in hemizygous mice (null/wild-type), suggesting that one functional MMP20 allele is sufficient for normal enamel development.
Similar to the g.16250T>A mutation, homozygosity of the previously identified MMP20 g.30561A>T mutation responsible for recessive pigmented hypomaturation AI is also associated with anterior open bite (Kim et al., 2005a) . Whether this is a biologic or serendipitous relationship is unknown. The intron 6 g.30561A>T mutation is predicted to cause aberrant splicing, but due to the restricted expression of MMP20, the effect at the mRNA level was not determined. The mutant mRNA generated by aberrant splicing likely undergoes nonsense-mediated decay, and individuals homozygous for the mutation would not produce functional MMP20, representing the equivalent of a null allele. Heterozygous carriers of the mutation did not show an altered enamel phenotype.
This study demonstrates that a mutation in the MMP20 active site results in hypomaturation AI. These findings corroborate those of Kim et al. (2005a) , that loss of function protease mutations underlie at least some forms of autosomalrecessive hypomaturation AI. However, 14 of the 15 families did not have detectable mutations in KLK4 or MMP20, suggesting that other genes account for the majority of hypomaturation AI in this Turkish population. While it is possible that other types of KLK4 and MMP20 mutations may be involved, such as promoter or intronic mutations or deletions that encompass whole exons, results of homozygosity linkage mapping studies in these families were not consistent for linkage in the regions spanning either the KLK4 (chromosome 16p13) or MMP20 (chromosome 11q22.3-q23) locus (data not shown). Identification of these genes and the continued cataloging of mutations underlying different forms of AI will provide a greater understanding of the molecular basis of enamel anomalies. This understanding should facilitate the development of a classification scheme that relates clinical phenotypes and underlying molecular mechanisms that may aid dentists in determining the most appropriate treatment course.
